dr forsyth on leptomeningeal disease in her2 breast cancer and tnbc
Published 4 months ago • 89 plays • Length 1:28Download video MP4
Download video MP3
Similar videos
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
4:50
case study 95 - dr. grunch explains leptomeningeal disease from breast cancer
-
59:51
leptomeningeal disease: overcoming treatment challenges through novel clinical trials
-
24:26
csf immune profiling in leptomeningeal disease | laura huppert, md & chris im, phd
-
1:20
challenges of treating patients with breast cancer with leptomeningeal metastasis
-
2:13
leptomeningeal carcinomatosis: brca-mutation related triple negative breast cancer
-
2:18
dr. hershman on the use of endocrine therapy in premenopausal hr /her2- breast cancer
-
4:11
potential evolutions in the tnbc treatment paradigm
-
8:32
immunotherapy for triple-negative breast cancer
-
4:31
new trials of targeting therapies to treat leptomeningeal carcinomatosis
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
9:39
#1 leptomeningeal disease- the basics
-
1:28
dr. tripathy on immunotherapy potential in her2-positive breast cancer
-
2:47
plus therapeutics' respect-lm clinical trial for patients with leptomeningeal metastases
-
5:02
leptomeningeal disease and its possible causes
-
20:05
diagnostic & treatment innovations in leptomeningeal carcinomatosis (lmc) - na tosha n. gatson, md
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
1:03
does being overweight affect your breast cancer risk?